Ligand Pharmaceuticals

LGNDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.783 B

$290.07 +2.32%

Close of 21 Sept 2026

Revenue

$268.1M

#2184 by revenue

Earnings

$124.5M

#1213 by earnings

Shares outstanding

19,935,609

Latest filing cover page

P/E ratio

46.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#49LiquidiaLQDA$5.95B
#50Travere TherapeuticsTVTX$5.93B
#51Ligand PharmaceuticalsLGND$5.78B
#52Cogent BiosciencesCOGT$5.55B
#53Ptc TherapeuticsPTCT$5.45B

What if Ligand Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$1,518,592

Per share 5,235× higher

Bitcoin $1.72T

$86,267.93

Per share 297× higher

Nvidia $5.48T

$274,877.88

Per share 948× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Ligand Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.